BICARA THERAPEUTICS INC. COMMON STOCK
NASDAQ: BCAX (Bicara Therapeutics Inc.)
Kemas kini terakhir: semalam, 12:33AM22.81
-0.29 (-1.26%)
| Penutupan Terdahulu | 23.10 |
| Jumlah Dagangan | 450,395 |
| Harga / Buku (P/B) | 3.26 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.69 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.13% |
| Nisbah Semasa (MRQ) | 24.62 |
| Aliran Tunai Operasi (OCF TTM) | -88.27 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.72 M |
| Pulangan Atas Aset (ROA TTM) | -13.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Bicara Therapeutics Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.75 |
|
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 11.65% |
| % Dimiliki oleh Institusi | 89.28% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Red Tree Management, Llc | 30 Jun 2026 | 3,163,517 |
| Tpg Gp A, Llc | 30 Jun 2026 | 3,010,425 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| COHLHEPP RYAN | - | 23.71 | -17,500 | -414,925 |
| Jumlah Keseluruhan Kuantiti Bersih | -17,500 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -414,925 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 23.71 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| COHLHEPP RYAN | Pegawai | 08 Sep 2026 | Jual automatik (-) | 17,500 | 23.71 | 414,925 |
| COHLHEPP RYAN | Pegawai | 08 Sep 2026 | Pelaksanaan pilihan | 17,500 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |